Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma-Reference-Cited by-同舟云学术

Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

Published:2024-09-10 Issue: Volume: Page:1-12
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Yildirim Hasan Cagri¹^ORCID,Bayram Ertuğrul²,Chalabiyev Elvin³,Majidova Nargız⁴,Avci Tugay⁵,Güzel Halil Göksel⁶,Kapar Caner⁷,Uzun Mehmet⁸,Perkin Perihan⁹,Akgül Fahri¹⁰,Yildirim Saadet Sim¹¹,Sali Seda¹²,Yildiz Anil¹³,Kazaz Seher Nazli¹⁴,Hendem Engin¹⁵,Arcagok Murat¹⁶,Tufan Gulnihal¹⁷,Yildirim Umit¹⁸,Akgul Omer Faruk¹⁹,Arslan Çagatay²⁰,Taban Hakan²¹,Sahin Eren²²,Caglayan Melek²³,Esen Ramazan¹⁸,Öksüzoğlu Berna¹⁷,Guven Deniz Can³,Kaplan Muhammet Ali¹⁶,Araz Murat¹⁵,Basaran Mert¹³,Cubukcu Erdem¹²,Gokmen Erhan¹¹,Cicin Irfan¹⁰,Algin Efnan⁹,Semiz Huseyin Salih⁸,Tural Deniz⁷,Ozturk Banu⁶,Erdogan Atike Pinar⁵,Sari Murat⁴,Kara Oguz²,Erman Mustafa³

Affiliation:

1. Department of Medical Oncology, Niğde Education and Research Hospital, Niğde, Turkey

2. Department of Medical Oncology, Çukurova University Faculty of Medicine, Adana, Turkey

3. Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey

4. Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey

5. Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey

6. Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey

7. Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey

8. Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey

9. Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey

10. Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey

11. Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey

12. Department of Medical Oncology, Uludag University Faculty of Medicine, Bursa, Turkey

13. Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey

14. Department of Medical Oncology, Medical Park Hospital, Trabzon, Turkey

15. Department of Medical Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey

16. Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey

17. Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey

18. Department of Medical Oncology, Yuzuncu Yil University Faculty of Medicine, Van, Turkey

19. Department of Medical Oncology, Adnan Menderes University Faculty of Medicine, Aydin, Turkey

20. Department of Medical Oncology, Medicalpoint Hospital, Izmir, Turkey

21. Department of Medical Oncology, Samsun Training and Research Hospital, Samsun, Turkey

22. Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey

23. Department of Medical Oncology, Selcuk University Faculty of Medicine, Konya, Turkey

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2403051

Reference25 articles.

1. Cancer statistics, 2022

2. Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

3. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

4. Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity

5. Therapy for Non-Clear Cell Histologies in Renal Cancer